Henry Schein Inc
NASDAQ:HSIC

  • LAST PRICE
    68.0000
  • TODAY'S CHANGE (%)
    -1.4300 (-2.0596%)
  • Bid / Lots
    67.5500/ 1
  • Ask / Lots
    68.3800/ 1
  • Open / Previous Close
    69.2000 / 69.4300
  • Day Range
    67.9055
    69.3800
  • 52 Week Range
    62.1200
    82.6300
  • Volume
    871,840

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
HSIC
Henry Schein Inc
8.5B
27.8x
+2.98%
SOLV
Solventum Corp
12.5B
11.8x
---
SNN
Smith & Nephew PLC
10.4B
34.8x
-16.83%
BLCO
Bausch + Lomb Corp
7.0B
-19.1x
---
OMI
Owens & Minor Inc
994.7M
-20.3x
---
TFX
Teleflex Inc
9.1B
38.8x
+12.49%
As of 2024-11-10

Company Information

Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. The Company operates through two segments: health care distribution, and technology and value-added services. The health care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products (including implant, orthodontic and endodontic products), diagnostic tests, infection-control products, personal protective equipment products and vitamins. The technology and value-added services segment provide software, technology and other value-added services to health care practitioners. It offers dental practice management solutions for dental and medical practitioners. It also develops solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist).

Contact Information

Headquarters
135 Duryea RdMELVILLE, NY, United States 11747
Phone
631-843-5500
Fax
302-636-5454

Executives

Chairman of the Board, Chief Executive Officer, Director
Stanley Bergman
President, Vice Chairman of the Board, Director
James Breslawski
Chief Financial Officer, Senior Vice President
Ronald South
Chief Executive Officer - International Distribution Group
Andrea Albertini
Co-Chief Executive Officer - Global Oral Reconstruction Group
Steve Boggan

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$8.5B
Revenue (TTM)
$12.5B
Shares Outstanding
124.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.84
EPS
$2.44
Book Value
$28.28
P/E Ratio
27.8x
Price/Sales (TTM)
0.7
Price/Cash Flow (TTM)
14.3x
Operating Margin
4.04%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.